CYP26A1 and neuroblastoma: Collectively, these data demonstrate that CYP26-specific, hydrophobic RAMBAs can be effectively incorporated into liposomes where their bioavailability remains effective at enhancing ATRA actions in neuroblastoma-derived cell lines.